B.C. Health Minister Adrian Dix speaks during a health-care funding announcement, in Vancouver on February 12, 2024. THE CANADIAN PRESS/Darryl Dyck
VANCOUVER — British Columbia is introducing a new cancer treatment option within the province for certain patients who have not responded well to standard chemotherapy or radiation therapy.
Known as Chimeric Antigen Receptor T-cell Therapy (CAR-T), this treatment targets lymphoma and leukemia by gathering a patient's white blood cells and modifying them genetically to identify and destroy cancerous cells.
Dr. Kim Chi, BC Cancer's chief medical officer, explains that previously, patients requiring this treatment would have to seek it outside the province or even the country.
Provincial Health Minister Adrian Dix announces that this year's budget allocates $14.3 million, enabling up to 20 adults and five children to receive treatment at Vancouver General Hospital or BC Children's Hospital starting this month.
Chi underscores that this therapy highlights the significant advancements in cancer treatment, propelled by state-of-the-art research and technology.
MJ Asrat, whose son Hugo underwent CAR-T therapy as part of a clinical trial, shared during the funding announcement that the treatment improved his health sufficiently to undergo a bone marrow transplant after enduring over three and a half years of chemotherapy for leukemia.
She joyfully revealed that her eight-year-old son is now cancer-free and rediscovering the simple joys of childhood.
Expressing gratitude, she extended her appreciation to the relentless medical researchers pushing the boundaries of science and the generous donors offering hope to families like hers.
